How Drug Makers Manipulate Patents to Keep Insulin Prices High

The financial burden of high insulin costs that patients and insurers face is often blamed on the Food and Drug Administration’s (FDA) regulatory framework, but a new study suggests pharmaceutical companies have also been using patenting processes to unfairly maintain high costs. In the FDA’s master list of approved medications, devices, and other therapeutics, a … Read more

A look back at the UKHSA annual conference for 2023

#UKHSA2023 brought together a range of people involved in public health and health protection science for speeches, panel discussions and exhibitions. It was a fascinating and busy 2 days in Leeds, with representatives joining from across the sector. As well as colleagues from across UKHSA, devolved administrations, local authorities, the NHS and Directors of Public … Read more